Showing results (901-910 of 991) with videos related to

Sort By:
Pageof 100
British Journal of Haematology|November 14, 2021
Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i)Sarah Gillessen, Andreas Hüttmann, Vladan Vucinic, et al.
ACS Infectious Diseases|October 21, 2016
Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformansRoss D Blundell, Simon J Williams, Samantha D M Arras, et al.
The Lancet. Oncology|February 26, 2017
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP<sub>escalated</sub> alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study GroupPeter Borchmann, Heinz Haverkamp, Andreas Lohri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2022
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort studyMihoko Imaji, Daichi Fujimoto, Yuki Sato, et al.
Nature Structural & Molecular Biology|August 1, 2017
Structural basis of TIR-domain-assembly formation in MAL- and MyD88-dependent TLR4 signalingThomas Ve, Parimala R Vajjhala, Andrew Hedger, et al.
Hemasphere|January 26, 2023
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell TherapyConrad-Amadeus Voltin, Philipp Gödel, Laura Beckmann, et al.
Chest|June 6, 2022
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World SettingYuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I StudyDaniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Cell|June 27, 2020
The Immunoglobulin Superfamily Receptome Defines Cancer-Relevant Networks Associated with Clinical OutcomeErik Verschueren, Bushra Husain, Kobe Yuen, et al.
Heart Rhythm|July 25, 2024
Appropriate and inappropriate ICD shocks in patients with LVADs: Prevalence, associated factors, and etiologiesAndrew Andreae, Eric Black-Maier, Kelly Arps, et al.
Pageof 100